Vertex Pharma (VRTX) November 11 weekly 475 straddle priced into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Vertex (VRTX) PT Raised to $451 at RBC Capital
November 5, 2024 7:00 AM ESTRBC Capital analyst Brian Abrahams raised the price target on Vertex (NASDAQ: VRTX) to $451.00 (from $437.00) while maintaining a Sector Perform rating.
The analyst comments "CF beat and raise shows the continued health of the company's core franchise and is likely to perpetuate... More



